Event Abstract

Morphological analysis of MCF-7 cells treated with chalcone derivatives

  • 1 Universiti Malaysia Terengganu, Malaysia
  • 2 Institute of Marine Biotechnology, Universiti Malaysia Terengganu, Malaysia
  • 3 School of Fundamental Science, Universiti Malaysia Terengganu, Malaysia
  • 4 Faculty of Bioresources and Food Industry, Universiti Sultan Zainal Abidin, Malaysia
  • 5 Faculty of Engineering Technology, Universiti Malaysia Perlis, Malaysia

Background Three chalcone derivatives substituted with nitro, trifluomethyl and cyano chalcone have been synthesised and characterised. They were then evaluated for their cytotoxicity potential in inhibiting the growth of MCF-7 cells. This is based on the presence of conjugated double bond within the molecular framework by having delocalised ℼ electrons system on both aromatic rings. Methods Fifty percent inhibition concentration (IC50) of all chalcone derivatives were obtained via the MTT assay. The morphological changes of the MCF-7 were then observed under light microscopy. Apoptosis in cells were examined through fluorescence acridine orange and propidium iodide staining. Phosphatidylserine (PS) exposure were determined by Annexin V staining and observed under fluorescence microscopy. Results Nitro and trifluoromethyl chalcone compounds showed active activity against MCF7 with IC50 values 14.75 and 13.75 µg/mL, respectively. Cyano chalcone was, however, found to be inactive (IC50 > highest tested concentration). Both active compounds have triggered morphological changes to the MCF-7 cells which included cell shrinkage, rounded and clumping. The compounds also induced apoptosis with cell blebbing. Other apoptosis indicator included PS localisation on the external phospholipid bilayer. Conclusion Based on cell morphological changes observed in the present study, nitro and trifluoromethyl chalcone compounds could potentially cause apoptosis in MCF-7 cells.

Acknowledgements

The author(s) would like to acknowledge School of Fundamental Science of UMT and Animal Tissue Culture Laboratory of UniSZA for financial and facilities support.

References

Chauhan S. S., Singh A. K., Meena S., Lohani, M., Singh, A., Arya, R. K., ... Chauhan, P. M. (2014). Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells. Bioorganic & Medicinal Chemistry Letters. 24(13):2820–2824. doi: 10.1016/j.bmcl.2014.04.109. Di Nunzio, M., Valli, V., Tomás-Cobos, L., Tomás-Chisbert, T., Murgui-Bosch, L., Danesi, F., & Bordoni, A. (2017). Is cytotoxicity a determinant of the different in vitro and in vivo effects of bioactives? BMC Complementary and Alternative Medicine. 17:453 https://doi.org/10.1186/s12906-017-1962-2 Jandial, D. D., Blair, C. A., Zhang, S., Krill, L. S., Zhang, Y., & Zi, X. (2014). Molecular targeted approaches to cancer therapy and prevention using chalcones. Curr Cancer Drug Targets. 14(2): 181–200. Karthikeyan, C., Narayana Moorthy, N. S. H., Ramasamy, S., Vanam, U., Manivannan, E., Karunagaran, D., & Trivedi, P. (2015). Advances in Chalcones with Anticancer Activities. Recent Patents on Anti-Cancer Drug Discovery. 10(1): 97-115. Kwan, Y. P., Ibrahim, D., Al-Hassan, F. M., Ein Oon, C., Chen, Y., Jothy, S. L., Kanwar, J. R., & Sasidharah, S. (2016). Evaluation of the cytotoxicity, cell-cycle arrest, and apoptotic induction by Euphorbia hirta in MCF-7 breast cancer cells. Pharm Biol. 54(7):1223-36. doi: 10.3109/13880209.2015.1064451.

Keywords: Chalcone, conjugated rings, MCF- 7 cancer cell line, Apoptosis, phosphatidylserine

Conference: International Conference on Drug Discovery and Translational Medicine 2018 (ICDDTM '18) “Seizing Opportunities and Addressing Challenges of Precision Medicine”, Putrajaya, Malaysia, 3 Dec - 5 Feb, 2019.

Presentation Type: Oral Presentation

Topic: Cancer

Citation: HASHIM F, Wan Mohamed Zin W, Mohamed M, Mohd Norhadi Shah N, Tuan Johari S, Daud A and RAHAMATHULLAH R (2019). Morphological analysis of MCF-7 cells treated with chalcone derivatives. Front. Pharmacol. Conference Abstract: International Conference on Drug Discovery and Translational Medicine 2018 (ICDDTM '18) “Seizing Opportunities and Addressing Challenges of Precision Medicine”. doi: 10.3389/conf.fphar.2018.63.00123

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 18 Nov 2018; Published Online: 17 Jan 2019.

* Correspondence: Miss. Adibah Izzati Daud, School of Fundamental Science, Universiti Malaysia Terengganu, Kuala Nerus, 21030, Malaysia, adizzati@gmail.com